Calluna Pharma AS, a clinical stage biotechnology company pioneering first-in-class antibodies to treat inflammatory and fibrotic diseases, today announced that Gijs van den Brink, MD, PhD, has been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback